Philips And Mediguide Announced Initiation Of Clinical Trials Using First Philips Cath Lab With Medical Positioning Technology

Main Category: Cardiovascular / Cardiology
Also Included In: Medical Devices;  Clinical Trials / Drug Trials
Article Date: 07 Apr 2008 - 16:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Philips and MediGuide announced they have started their planned clinical trials in the USA in the Columbia New York Presbyterian (NYP) Hospital under IDE using the Philips Integris Allura Flat Detector catheterization (cath) lab (Allura FD-10) integrated with MediGuide's Medical Positioning System (gMPS™) technology and using the MediGuide gMPS™ Enabled Guided Measurement Catheter (GMC™).

Royal Philips Electronics (NYSE: PHG, AEX: PHI) and MediGuide Ltd. (Haifa, Israel) have been cooperating since 2003 in the field on cardiac navigation. The gMPS™ system and the GMC™ device are CE Mark certified and are limited to investigational use only in the U.S.

The gMPS™ system is intended for intravascular evaluation of coronary anatomy. It is intended to enable real time tip positioning and navigation of an gMPS™ enabled (equipped with an gMPS™ sensor) diagnostic or therapeutic invasive device used in coronary or cardiac intervention in the Cath Lab environment, on both live fluoroscopy or recorded background. The System is indicated for use as an adjunct to coronary angiography.

The gMPS™ enabled GMC™ intravascular device is intended to be used in conjunction with conventional X-ray angiography systems to enable real-time tip positioning and navigation, quantitative length measurement, 3D lumen reconstruction, qualitative 3D foreshortening indication and landmarking, in patients who are candidates for coronary angiography and/or Percutaneous Coronary Intervention (PCI).

The trial is conducted by Dr. Giora Weisz and Jeffrey W. Moses from Columbia NYP. Dr. Moses said after the first patient: "The system performed beautifully. It is the first step of moving beyond fluoroscopy in coronary intervention. The potential here is enormous!"

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 125,800 employees in more than 60 countries worldwide. With sales of USD 34 billion (EUR 27 billion) in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at http://www.philips.com/newscenter.

About MediGuide

MediGuide (Delaware, USA & Haifa, Israel) - an Israeli based company (originally spun off from Elbit Systems - NASDAQ: ESLT), is the provider of technology, solutions and applications for intra body navigation and less invasive procedures with a special focus on cardiology. Based on its proprietary MPS technology, MediGuide brings the ability to navigate MPS Enabled Devices (catheters, wires and other devices equipped with a sub millimeter MPS sensor) in the MPS Ready Cathlab environment, co-developed by MediGuide in collaboration with the leading imaging companies.

MediGuide